| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 12 | 2019 | 94 | 3.630 |
Why?
|
| Polymorphism, Single Nucleotide | 22 | 2016 | 1062 | 2.490 |
Why?
|
| Mass Spectrometry | 8 | 2017 | 102 | 1.610 |
Why?
|
| Genomics | 3 | 2019 | 85 | 1.480 |
Why?
|
| Metabolomics | 3 | 2019 | 54 | 1.330 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 3 | 2019 | 28 | 1.300 |
Why?
|
| Sequence Analysis, DNA | 11 | 2013 | 137 | 1.260 |
Why?
|
| Genome, Human | 10 | 2012 | 132 | 1.210 |
Why?
|
| DNA-Binding Proteins | 5 | 2016 | 147 | 1.110 |
Why?
|
| DNA | 6 | 2014 | 226 | 1.100 |
Why?
|
| Insulin Resistance | 4 | 2021 | 462 | 1.040 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2018 | 19 | 1.010 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2018 | 21 | 0.910 |
Why?
|
| Chromatin | 5 | 2016 | 25 | 0.850 |
Why?
|
| Genotype | 12 | 2019 | 733 | 0.840 |
Why?
|
| Papio | 3 | 2019 | 91 | 0.810 |
Why?
|
| Algorithms | 7 | 2013 | 495 | 0.790 |
Why?
|
| Sirtuins | 1 | 2021 | 20 | 0.790 |
Why?
|
| Haplotypes | 10 | 2013 | 220 | 0.780 |
Why?
|
| Animals | 27 | 2021 | 7542 | 0.770 |
Why?
|
| Proteome | 3 | 2014 | 39 | 0.750 |
Why?
|
| Membrane Proteins | 2 | 2016 | 256 | 0.750 |
Why?
|
| Lipoproteins | 2 | 2012 | 86 | 0.740 |
Why?
|
| Kidney Medulla | 3 | 2018 | 29 | 0.730 |
Why?
|
| Serum | 2 | 2019 | 19 | 0.680 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2016 | 18 | 0.670 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 495 | 0.640 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 19 | 0.630 |
Why?
|
| Kidney Cortex | 1 | 2018 | 25 | 0.620 |
Why?
|
| Metabolome | 1 | 2018 | 36 | 0.620 |
Why?
|
| Quantitative Trait Loci | 6 | 2015 | 140 | 0.610 |
Why?
|
| Genetic Variation | 5 | 2016 | 244 | 0.600 |
Why?
|
| Obesity | 9 | 2016 | 1176 | 0.600 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 28 | 0.600 |
Why?
|
| Humans | 45 | 2019 | 32114 | 0.600 |
Why?
|
| Databases, Genetic | 2 | 2017 | 37 | 0.580 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2016 | 2 | 0.560 |
Why?
|
| Body Fat Distribution | 2 | 2016 | 34 | 0.560 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2016 | 22 | 0.550 |
Why?
|
| Computational Biology | 5 | 2019 | 91 | 0.550 |
Why?
|
| Galactokinase | 1 | 2016 | 1 | 0.550 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2016 | 11 | 0.550 |
Why?
|
| Liver | 3 | 2021 | 484 | 0.530 |
Why?
|
| Mutation | 2 | 2016 | 489 | 0.530 |
Why?
|
| Carrier Proteins | 1 | 2016 | 136 | 0.510 |
Why?
|
| Triglycerides | 4 | 2012 | 230 | 0.490 |
Why?
|
| Software | 5 | 2007 | 123 | 0.480 |
Why?
|
| Fatty Liver | 2 | 2011 | 66 | 0.470 |
Why?
|
| Disease Progression | 1 | 2016 | 594 | 0.470 |
Why?
|
| Genetic Markers | 5 | 2016 | 124 | 0.460 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2013 | 10 | 0.450 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2008 | 33 | 0.450 |
Why?
|
| Radiation Hybrid Mapping | 3 | 2004 | 4 | 0.440 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2013 | 3 | 0.430 |
Why?
|
| Dogs | 6 | 2007 | 120 | 0.430 |
Why?
|
| Mitochondria, Heart | 1 | 2013 | 17 | 0.430 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 6 | 0.430 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 13 | 0.430 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2009 | 60 | 0.420 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 107 | 0.400 |
Why?
|
| PPAR gamma | 1 | 2011 | 46 | 0.400 |
Why?
|
| Isotope Labeling | 3 | 2008 | 16 | 0.390 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2008 | 7 | 0.390 |
Why?
|
| Genetic Techniques | 1 | 2011 | 7 | 0.390 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2011 | 4 | 0.390 |
Why?
|
| Protein Tyrosine Phosphatases | 4 | 2005 | 17 | 0.370 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 41 | 0.370 |
Why?
|
| European Continental Ancestry Group | 5 | 2016 | 1166 | 0.370 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 73 | 0.340 |
Why?
|
| Apolipoproteins | 4 | 2004 | 200 | 0.340 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 94 | 0.340 |
Why?
|
| Hearing Loss | 1 | 2009 | 26 | 0.340 |
Why?
|
| Models, Genetic | 4 | 2013 | 94 | 0.330 |
Why?
|
| Genetic Testing | 1 | 2009 | 96 | 0.330 |
Why?
|
| Biological Assay | 1 | 2009 | 19 | 0.330 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2009 | 24 | 0.320 |
Why?
|
| Down Syndrome | 1 | 2008 | 14 | 0.320 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 547 | 0.320 |
Why?
|
| Statistics as Topic | 1 | 2009 | 108 | 0.320 |
Why?
|
| Y Chromosome | 2 | 1999 | 43 | 0.320 |
Why?
|
| Polymerase Chain Reaction | 7 | 2014 | 198 | 0.310 |
Why?
|
| Linkage Disequilibrium | 7 | 2012 | 185 | 0.310 |
Why?
|
| Databases, Nucleic Acid | 1 | 2007 | 5 | 0.310 |
Why?
|
| Male | 20 | 2019 | 19217 | 0.310 |
Why?
|
| Gene Frequency | 6 | 2011 | 220 | 0.300 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2004 | 8 | 0.290 |
Why?
|
| Rats | 8 | 2013 | 1596 | 0.290 |
Why?
|
| Alleles | 5 | 2013 | 248 | 0.280 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2006 | 19 | 0.280 |
Why?
|
| Female | 19 | 2019 | 20015 | 0.280 |
Why?
|
| Endothelial Cells | 4 | 2008 | 189 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2016 | 835 | 0.270 |
Why?
|
| Hypertension | 4 | 2010 | 960 | 0.270 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2016 | 20 | 0.260 |
Why?
|
| Adult | 9 | 2016 | 9380 | 0.250 |
Why?
|
| Feeding Behavior | 1 | 2006 | 161 | 0.250 |
Why?
|
| Chromatography, Liquid | 4 | 2008 | 43 | 0.250 |
Why?
|
| Multigene Family | 2 | 2004 | 51 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2004 | 24 | 0.240 |
Why?
|
| Oxygen Isotopes | 4 | 2008 | 7 | 0.230 |
Why?
|
| Middle Aged | 11 | 2016 | 11839 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Lipids | 3 | 2013 | 232 | 0.220 |
Why?
|
| Diet | 2 | 2021 | 391 | 0.220 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
| Cohort Studies | 6 | 2016 | 1817 | 0.210 |
Why?
|
| Genetic Loci | 2 | 2016 | 146 | 0.210 |
Why?
|
| Histones | 2 | 2014 | 53 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
| Chromosome Mapping | 7 | 2007 | 193 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 297 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 208 | 0.200 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 2 | 1999 | 3 | 0.200 |
Why?
|
| Cluster Analysis | 3 | 2008 | 125 | 0.200 |
Why?
|
| Adipocytes | 2 | 2016 | 81 | 0.200 |
Why?
|
| Fructose | 1 | 2021 | 11 | 0.200 |
Why?
|
| Organ Specificity | 2 | 2019 | 81 | 0.200 |
Why?
|
| Transcription Factors | 3 | 2014 | 181 | 0.190 |
Why?
|
| Protein Binding | 3 | 2016 | 201 | 0.190 |
Why?
|
| Pedigree | 4 | 2016 | 140 | 0.180 |
Why?
|
| Insulin | 3 | 2013 | 367 | 0.180 |
Why?
|
| Sequence Tagged Sites | 4 | 2004 | 5 | 0.170 |
Why?
|
| Reproducibility of Results | 4 | 2007 | 765 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 940 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 78 | 0.170 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 17 | 0.170 |
Why?
|
| Carnivora | 1 | 1999 | 2 | 0.160 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 29 | 0.160 |
Why?
|
| Cholesterol, Dietary | 1 | 2019 | 36 | 0.160 |
Why?
|
| Apolipoproteins A | 3 | 2003 | 25 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 60 | 0.160 |
Why?
|
| Dyslipidemias | 2 | 2009 | 53 | 0.160 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2007 | 160 | 0.160 |
Why?
|
| Genes, Dominant | 2 | 2016 | 27 | 0.150 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 75 | 0.150 |
Why?
|
| Reference Standards | 1 | 2017 | 32 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2008 | 96 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 155 | 0.150 |
Why?
|
| Calcium | 1 | 2019 | 307 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2016 | 8 | 0.140 |
Why?
|
| Adiponectin | 2 | 2013 | 106 | 0.130 |
Why?
|
| Lod Score | 2 | 2013 | 72 | 0.130 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 359 | 0.130 |
Why?
|
| Peptides | 2 | 2007 | 120 | 0.130 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2015 | 20 | 0.130 |
Why?
|
| Wisconsin | 2 | 2012 | 21 | 0.130 |
Why?
|
| Receptor, Melanocortin, Type 1 | 2 | 2007 | 6 | 0.130 |
Why?
|
| Cholesterol | 4 | 2019 | 252 | 0.130 |
Why?
|
| Asian Continental Ancestry Group | 2 | 2005 | 108 | 0.120 |
Why?
|
| Genetics, Population | 2 | 2005 | 32 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 105 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2016 | 469 | 0.120 |
Why?
|
| Human Genome Project | 3 | 2003 | 3 | 0.120 |
Why?
|
| Young Adult | 3 | 2016 | 2665 | 0.110 |
Why?
|
| Computer Graphics | 1 | 2013 | 10 | 0.110 |
Why?
|
| DNA Primers | 3 | 2005 | 91 | 0.110 |
Why?
|
| Apolipoproteins C | 2 | 2003 | 4 | 0.110 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 8 | 0.110 |
Why?
|
| Rats, Wistar | 1 | 2013 | 79 | 0.110 |
Why?
|
| London | 1 | 2012 | 2 | 0.110 |
Why?
|
| Endocrinology | 1 | 2012 | 2 | 0.110 |
Why?
|
| Egypt | 1 | 2012 | 13 | 0.110 |
Why?
|
| Adolescent | 3 | 2016 | 3568 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2019 | 766 | 0.110 |
Why?
|
| Phenotype | 5 | 2016 | 632 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2012 | 71 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 104 | 0.100 |
Why?
|
| Neoplasms | 1 | 2019 | 728 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 285 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2001 | 40 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 7 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 146 | 0.100 |
Why?
|
| Phosphopeptides | 1 | 2011 | 3 | 0.100 |
Why?
|
| Ions | 1 | 2011 | 12 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 27 | 0.100 |
Why?
|
| Caseins | 1 | 2011 | 14 | 0.100 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 2004 | 14 | 0.100 |
Why?
|
| Trypsin | 2 | 2008 | 11 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2016 | 2283 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 3990 | 0.090 |
Why?
|
| Aged | 3 | 2016 | 10314 | 0.090 |
Why?
|
| Amidohydrolases | 1 | 2009 | 8 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2013 | 220 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 1128 | 0.090 |
Why?
|
| Neonatal Screening | 1 | 2009 | 12 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2009 | 35 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 322 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2016 | 898 | 0.080 |
Why?
|
| Comorbidity | 1 | 2010 | 566 | 0.080 |
Why?
|
| Lectins | 1 | 2008 | 10 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 15 | 0.080 |
Why?
|
| Blotting, Southern | 2 | 1999 | 24 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2005 | 18 | 0.080 |
Why?
|
| Complex Mixtures | 1 | 2008 | 3 | 0.080 |
Why?
|
| Horses | 2 | 2005 | 15 | 0.080 |
Why?
|
| Myoglobin | 2 | 2005 | 11 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2008 | 834 | 0.080 |
Why?
|
| Cattle | 1 | 2008 | 103 | 0.080 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2008 | 56 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2007 | 15 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 33 | 0.080 |
Why?
|
| Base Sequence | 3 | 2011 | 252 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2007 | 60 | 0.070 |
Why?
|
| Body Mass Index | 3 | 2008 | 923 | 0.070 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 14 | 0.070 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 27 | 0.070 |
Why?
|
| Chromosome Segregation | 1 | 2007 | 3 | 0.070 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 21 | 0.070 |
Why?
|
| Hair Color | 1 | 2007 | 3 | 0.070 |
Why?
|
| Chloroform | 1 | 2007 | 1 | 0.070 |
Why?
|
| Pigmentation | 2 | 2007 | 6 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 41 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 156 | 0.070 |
Why?
|
| Epistasis, Genetic | 1 | 2007 | 44 | 0.070 |
Why?
|
| Proteins | 1 | 2008 | 144 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 412 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2009 | 672 | 0.070 |
Why?
|
| Peptide Hormones | 1 | 2006 | 11 | 0.070 |
Why?
|
| Environment | 1 | 2006 | 54 | 0.070 |
Why?
|
| Mice | 3 | 2019 | 2484 | 0.070 |
Why?
|
| Flap Endonucleases | 1 | 2005 | 1 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 392 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1022 | 0.060 |
Why?
|
| Rabbits | 1 | 2005 | 197 | 0.060 |
Why?
|
| Gene Components | 1 | 2004 | 3 | 0.060 |
Why?
|
| Japan | 1 | 2004 | 17 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 112 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 22 | 0.060 |
Why?
|
| China | 1 | 2004 | 50 | 0.060 |
Why?
|
| African Continental Ancestry Group | 1 | 2005 | 363 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2005 | 85 | 0.060 |
Why?
|
| Allelic Imbalance | 1 | 2004 | 6 | 0.060 |
Why?
|
| Hyperlipidemia, Familial Combined | 1 | 2003 | 3 | 0.060 |
Why?
|
| Learning | 1 | 2004 | 79 | 0.060 |
Why?
|
| Apolipoprotein A-I | 1 | 2003 | 68 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2003 | 3 | 0.060 |
Why?
|
| Leukocytes | 2 | 2013 | 57 | 0.050 |
Why?
|
| Biotechnology | 1 | 2002 | 6 | 0.050 |
Why?
|
| Fibrosis | 1 | 2003 | 120 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2003 | 244 | 0.050 |
Why?
|
| Contig Mapping | 1 | 2001 | 3 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2013 | 508 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2001 | 8 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1538 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2003 | 231 | 0.050 |
Why?
|
| Chromosome Aberrations | 1 | 2001 | 23 | 0.050 |
Why?
|
| Child | 1 | 2006 | 2442 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2001 | 355 | 0.040 |
Why?
|
| Asparagine | 1 | 2019 | 6 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2019 | 48 | 0.040 |
Why?
|
| Radiometry | 1 | 2019 | 40 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 77 | 0.040 |
Why?
|
| Foxes | 1 | 1999 | 1 | 0.040 |
Why?
|
| Hip Dysplasia, Canine | 1 | 1999 | 1 | 0.040 |
Why?
|
| Wolves | 1 | 1999 | 1 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 68 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 115 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 1999 | 21 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2019 | 53 | 0.040 |
Why?
|
| Iliac Artery | 1 | 2019 | 49 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 75 | 0.040 |
Why?
|
| Species Specificity | 1 | 1999 | 90 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 114 | 0.040 |
Why?
|
| Aorta | 1 | 2019 | 126 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 99 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 85 | 0.040 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 1998 | 5 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1998 | 10 | 0.040 |
Why?
|
| Chagas Disease | 1 | 2017 | 7 | 0.040 |
Why?
|
| Body Weights and Measures | 2 | 2009 | 24 | 0.040 |
Why?
|
| Primates | 1 | 2017 | 108 | 0.040 |
Why?
|
| Europe | 2 | 2009 | 82 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2017 | 106 | 0.030 |
Why?
|
| Agouti Signaling Protein | 2 | 2007 | 2 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 8 | 0.030 |
Why?
|
| Ribosomes | 1 | 2014 | 10 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2008 | 47 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2013 | 845 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 767 | 0.030 |
Why?
|
| Ethnic Groups | 1 | 2016 | 476 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2013 | 7 | 0.030 |
Why?
|
| Apolipoprotein C-III | 2 | 2003 | 5 | 0.030 |
Why?
|
| Myosins | 1 | 2013 | 10 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Cadherins | 1 | 2013 | 26 | 0.030 |
Why?
|
| CpG Islands | 1 | 2013 | 45 | 0.030 |
Why?
|
| Particle Size | 1 | 2013 | 46 | 0.030 |
Why?
|
| Exons | 1 | 2013 | 52 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 57 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 120 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2013 | 173 | 0.030 |
Why?
|
| Formaldehyde | 1 | 2011 | 11 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 141 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2011 | 16 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2011 | 19 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 87 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 30 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2011 | 87 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3306 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 126 | 0.020 |
Why?
|
| Inflammation | 1 | 2013 | 530 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 105 | 0.020 |
Why?
|
| Nuclear Family | 1 | 2008 | 15 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2008 | 8 | 0.020 |
Why?
|
| Homeostasis | 1 | 2008 | 132 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2008 | 111 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2007 | 11 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 35 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 45 | 0.020 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 2007 | 2 | 0.020 |
Why?
|
| Chromosomes | 1 | 2007 | 9 | 0.020 |
Why?
|
| Time Factors | 2 | 2003 | 2151 | 0.020 |
Why?
|
| Microscopy | 1 | 2007 | 26 | 0.020 |
Why?
|
| Binding Sites | 1 | 2007 | 130 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2007 | 229 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 582 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2005 | 12 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2005 | 2 | 0.020 |
Why?
|
| Body Size | 1 | 2005 | 34 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2004 | 3 | 0.020 |
Why?
|
| Energy Intake | 1 | 2005 | 128 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2004 | 15 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 293 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 78 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2005 | 147 | 0.010 |
Why?
|
| Rats, Inbred Dahl | 1 | 2003 | 1 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 31 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 2003 | 31 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 28 | 0.010 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2003 | 28 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 289 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 2001 | 17 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2004 | 494 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 743 | 0.010 |
Why?
|
| Radiography | 1 | 1999 | 376 | 0.010 |
Why?
|